![china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c4[1]](https://chinameddevice.com/wp-content/uploads/2018/09/china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c41.png){kind=logo}
April 29, 2019
NMPA (CFDA) issued Notice on Classification Procedures for Combination Device on April 17th. The new procedures will be effective on June 1, 2019: A specialized department, NMPA Standardization Management Center […]
April 24, 2019
NMPA (CFDA) issued “Medical Device Animal Study Technical Review Guideline Part I: Decision Principles” on April 19. The guideline lists 12 devices as examples to discuss if animal study is […]
April 22, 2019
Clinical trial protocol is a vital component in IVD clinical design and, in China, the details of the protocol never fail to be questioned by NMPA (CFDA) reviewers. ChinaMed Device, […]
April 19, 2019
“Electronic Regulated Product Submission (eRPS) will come into force by the end of June, 2019”, Zhong Lu, deputy head of NMPA Center for Medical Device Evaluation (CMDE), announced at the […]
April 11, 2019
The International Congress of Ophthalmology and Optometry China (COOC) 2019 was held on March 22-24, 2019 in Shanghai, China. Myopia Management White Paper (2019) was released as well. COOC was […]